在制劑(ji)仿制開發的(de)(de)(de)要素中，國內制劑(ji)企(qi)業(ye)的(de)(de)(de)瓶(ping)頸(jing)是(shi)(shi)(shi)藥用輔(fu)料(liao)的(de)(de)(de)受限，在已正式頒(ban)布實施(shi)的(de)(de)(de)2020年(nian)(nian)版《中國藥典》四部(bu)中，輔(fu)料(liao)收載品種由2005年(nian)(nian)的(de)(de)(de)76個增加(jia)(jia)到了(le)目前(qian)的(de)(de)(de)335個，收載品種數量(liang)(liang)增加(jia)(jia)了(le)5倍。而制劑(ji)的(de)(de)(de)應(ying)用才是(shi)(shi)(shi)藥用輔(fu)料(liao)的(de)(de)(de)終極(ji)目的(de)(de)(de)，輔(fu)料(liao)性能的(de)(de)(de)提(ti)升也極(ji)大(da)(da)有利于制劑(ji)質(zhi)量(liang)(liang)的(de)(de)(de)保(bao)障。近年(nian)(nian)來，國內涌現出一批技術含量(liang)(liang)高、規模(mo)效益好的(de)(de)(de)優質(zhi)輔(fu)料(liao)生產企(qi)業(ye)，輔(fu)料(liao)聯盟(meng)(meng)近期會(hui)約請這些(xie)企(qi)業(ye)，為大(da)(da)家介紹一下它(ta)們(men)與制劑(ji)研發相關的(de)(de)(de)一些(xie)成果(guo)，本周六（2021.12.11）上午九點鐘輔(fu)料(liao)聯盟(meng)(meng)邀請的(de)(de)(de)企(qi)業(ye)是(shi)(shi)(shi)安(an)徽山河藥輔(fu)和西安(an)德立生物，請他(ta)們(men)分別講一下微晶纖維素和倍他(ta)環糊精及(ji)其衍(yan)生物等(deng)輔(fu)料(liao)的(de)(de)(de)性能、參(can)數對(dui)比，望大(da)(da)家屆時收看

       Among the elements of preparation generic development, the bottleneck of domestic preparation enterprises is the limitation of excipients. In the volume IV of the Chinese Pharmacopoeia (2020 edition), the number of excipients has increased from 76 in 2005 to 335 at present, increased for 5 times. The application in preparation is the ultimate purpose of excipients, and the improvement of excipients performance is also beneficial to the guarantee of the quality of preparation. In recent years, a number of high-quality excipients manufacturers with advanced technology and large scale have emerged in China. The Excipients manufacturing quality group will invite these enterprises to introduce some of their achievements related to preparation R&D. At 9:00AM this Saturday (2021.12.11), the enterprises Anhui Sunhere Pharmaceutical Excipients Co., Ltd and Xi'an DELI Biochemical Industry Co., Ltd. will talk about the performance and parameter comparison of microcrystalline cellulose, beta cyclodextrin and its derivatives. Please join in to watch online and discuss.